Article
ASCO says that it's Patient-Centered Oncology Payment model meets the criteria for an Alternative Payment Model as defined by Congress in the Medicare Access and CHIP Reauthorization Act of 2015, which replaced the Sustainable Growth Rate formula.
The American Society of Clinical Oncology (ASCO) has released the Patient-Centered Oncology Payment (PCOP) model, which expands on ASCO's payment reform proposal from last year. The organization claims that PCOP qualifies as an Alternative Payment Model as defined by the Medicare Access and CHIP Reauthorization Act of 2015 that was released by Congress last month to replace Medicare's widely criticized Sustainable Growth Rate formula.
According to ASCO PCOP will address the following:
Read the complete news release by ASCO: http://bit.ly/1Gs2ygI